49% lower 30-day readmission rate in a COPD hospital pilot.
One hospital's 30-day rate fell 14.4% to 7.3% (2019 to 2022).
Review the evidence
Impact of a respiratory muscle strength training program on hospital readmissions in patients with COPD: a retrospective pilot study. Vora J, Morey S. American Journal of Speech-Language Pathology, 2026. Retrospective pilot study. doi:10.1044/2026_AJSLP-25-00613
What does it mean? Plain-language article → Read the full study on the journal site →
What they did
A speech-language pathology team at a rural acute-care hospital ran a year-long RMT program in 2022 for adults admitted with COPD exacerbations. Patients got inspiratory and expiratory RMT, starting during the admission.
How they compared it
30-day readmissions in the program year were compared with a pre-program year (2019) at the same hospital, and with a comparable hospital in the same system that didn't run the program. They used two-proportion z tests and effect sizes. Feasibility and cost were described, not tested.
What they reported
That's a 7.1-percentage-point absolute and 49.3% relative reduction. It was not statistically significant within the site. 2022 readmissions were significantly lower than at the comparison hospital.
What the authors concluded
Starting SLP-led RMT during a COPD admission appears feasible and cost-effective, and is associated with a promising reduction in readmissions. Given the retrospective design and the non-significant within-site comparison, causal conclusions cannot be drawn. They call for prospective research.
Read these numbers with their limits
- Retrospective design: one hospital's records, 2022 vs a historical 2019 year. Not randomized.
- Within-site change was not statistically significant (7.1-point absolute, 49.3% relative reduction).
- 2022 readmissions were significantly lower than at the comparison hospital in the same system.
- The authors state that causal conclusions cannot be drawn and call for prospective studies.
- The abstract describes inhale-and-exhale RMT. It does not name a device.
Take the study to your team
A specialist covers the study, its limits and practical setup in a staff in-service.
Request a staff in-serviceRead the study's limits, summarized above.
Source: published abstract.
Related articles and context
Articles on TheBreather.com. Read each against the original research.
